The link of heparanase to inflammatory bowel disease is based on results obtained in a mouse model over-expressing heparanase, in which the inflammatory profile of macrophages was preserved for more than a month after termination of the pro-inflammatory DSS treatment [39]. Here, HPSE is linked to inflammatory bowel disease.